This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PIP Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PIP WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~16.6 kDa | |
| Gel | 15% (standard starting point) | |
| Positive control | Salivary gland (IHC candidate; verify WB) +1 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Glycosylated + Cleaved | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The M04543-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | T47D cell lysate (catalog M04543-2) |
| Gel % | 15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.2 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M04543-2; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
PIP has a predicted 16.6 kDa precursor; signal peptide cleavage and Asn105 glycosylation may affect migration, but no empirical band or feature-specific shift is established.
| Band near 16.6 kDa | May represent the full-length precursor; confirm band identity |
| Band below the precursor position | May reflect removal of the 1–28 signal peptide |
| Band above an unglycosylated form | Could reflect N-linked glycosylation at Asn105; a visible shift is unproven |
| Little or no band in whole-cell lysate | PIP is secreted and may be more abundant in conditioned medium |
| Predicted precursor mass | 16.6 kDa before signal peptide removal or modification |
| Signal peptide at residues 1–28 | cleavage produces a smaller mature chain than the precursor |
| N-linked glycosylation site at Asn105 | glycosylation could increase apparent size; the shift is not established |
| Unglycosylated Asn105 form | could migrate below a glycosylated form if both are present |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | PIP is secreted | check conditioned medium and a positive control |
| Band higher than expected | possible Asn105 glycosylation; the size effect is unverified | compare untreated and deglycosylated samples with a positive control |
| Band lower than expected | signal peptide removal may yield a smaller mature chain | compare lysate and conditioned medium and verify antibody specificity |
| Multiple bands | precursor and mature forms or differing Asn105 glycosylation may be present | compare sample fractions and use a specificity control |
| Weak or no signal | secreted PIP may be scarce in the sampled lysate | test conditioned medium and a known positive sample |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Salivary gland | glandular cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for PIP, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The listed anti-PIP antibody, M04543-2, is a rabbit monoclonal with stated human reactivity. Its Western blot image shows GCDFP 15 expression in T47D cell lysate. No broader sample or species validation is supplied.
Which to pick: M04543-2 is the only listed option and has a Western blot image from T47D cell lysate. Consider it for human PIP Western blotting; performance in other samples is not established by the supplied evidence.